Feng Lou
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
Papers in
-
- Cancer Genomics and Diagnostics 22
-
- Lung Cancer Treatments and Mutations 11
- Co-authors
- Wei Chen (5 shared papers)Mingyu Zhao (5 shared papers)Lindsey Jones (4 shared papers)Hua Ye (4 shared papers)Xue F. Huang (3 shared papers)Rong Shi (3 shared papers)Kezhong Chen (4 shared papers)Fan Yang (4 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Cancer Medicine (4 papers)Frontiers in Oncology (4 papers)Scientific Reports (2 papers)Journal of Thoracic and Cardiovascular Surgery (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Feng Lou
35 papers receiving 525 citations
Peers
Comparison fields: 5 of 48
- Cancer Research 334
- Pulmonary and Respiratory Medicine 324
- Oncology 186
- Pathology and Forensic Medicine 97
- Hematology 27
Countries citing papers authored by Feng Lou
This map shows the geographic impact of Feng Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Lou more than expected).
Fields of papers citing papers by Feng Lou
This network shows the impact of papers produced by Feng Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Lou. The network helps show where Feng Lou may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Lou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 101 | |
| 2 | 2016 | 92 | |
| 3 | 2015 | 85 | |
| 4 | 2017 | 45 | |
| 5 | 2017 | 42 | |
| 6 | 2021 | 30 | |
| 7 | 2015 | 26 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 10 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2022 | 6 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2023 | 3 | |
| 20 | A novel prognostic scoring model for newly diagnosed FLT3-ITD-positive acute myeloid leukemia. | 2020 | 3 |
About Feng Lou
Feng Lou is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 40 papers that have together received 529 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (22 papers), Lung Cancer Treatments and Mutations (11 papers), Genetic factors in colorectal cancer (9 papers), Colorectal Cancer Treatments and Studies (6 papers), Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Cancer Research (334 citations), Pulmonary and Respiratory Medicine (324 citations), Oncology (186 citations), Pathology and Forensic Medicine (97 citations) and Hematology (27 citations). Feng Lou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wei Chen, Mingyu Zhao, Lindsey Jones, Hua Ye, Xue F. Huang, Rong Shi, Kezhong Chen, Fan Yang, Si–Yi Chen and Shanbo Cao. Their work appears in journals such as Journal of Clinical Oncology, Cancer Medicine, Frontiers in Oncology, Scientific Reports and Journal of Thoracic and Cardiovascular Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.